Publication Name	World Journal of Stem Cells
Manuscript ID	12940
Country	United States

Received	2014-07-29 09:03
Peer-Review Started	2014-07-29 17:58
To Make the First Decision	2014-08-14 14:32
Return for Revision	2014-08-18 12:06
Revised	2014-09-03 10:14
Second Decision	2014-10-16 15:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-10-16 16:09
Articles in Press	2014-10-16 16:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-12-19 09:34
Publish the Manuscript Online	2015-01-14 11:53

ISSN	1948-0210 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Minireviews
Article Title	Stem cell therapy for retinal diseases
Manuscript Source	Invited Manuscript
All Author List	José Mauricio Garcia, Luisa Mendonça, Rodrigo Brant, Murilo Abud, Caio Regatieri and Bruno Diniz
Funding Agency and Grant Number
Corresponding Author	Bruno Diniz, MD, PhD, Department of Ophthalmology, Universidade Federal de Goiás, Al. Ricardo Paranhos, 799, Goiânia 74001-970, Brazil. dinizb@me.com
Key Words	Macular degeneration; Human embryonic stem cell; Induced pluripotent stem cell; Retinal pigment epithelium; Stargardt’s disease
Core Tip	The stem cell (SC) retinal therapy has turned into an potentially useful way of treating blinding disorders, such as, Stargadt’s dystrophy, and geographic atrophy. The Food and Drug Administration’s approval for clinical trials using SC retinal therapy, and its good results, may appoint to future promising outcomes, providing an anatomical restoration of the retina, and a functional improval of visual function of several patients.
Publish Date	2015-01-14 11:53
Citation	Garcia JM, Mendonça L, Brant R, Abud M, Regatieri C, Diniz B. Stem cell therapy for retinal diseases. World J Stem Cells 2015; 7(1): 160-164
URL	http://www.wjgnet.com/1948-0210/full/v7/i1/1.htm
DOI	http://dx.doi.org/10.4252/wjsc.v7.i1.1

Manuscript File	12940-Review.docx
Answering Reviewers	12940-Answering reviewers.pdf
Copyright License Agreement	12940-Copyright assignment.pdf
Peer-review Report	12940-Peer review(s).pdf
Scientific Misconduct Check	12940-CrossCheck.jpg
Scientific Editor Work List	12940-Scientific editor work list.pdf